Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial-Reference-Cited by-同舟云学术

Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

Published:2022-01-17 Issue:2 Volume:36 Page:1023-1031
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Asadirad Ali¹²^ORCID,Nashibi Roohangiz³,Khodadadi Ali¹²,Ghadiri Ata A¹,Sadeghi Mahvash¹⁴,Aminian Azam²⁵,Dehnavi Sajad¹^ORCID

Affiliation:

1. Department of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

2. Cancer, Petroleum and Environmental Pollutants Research Center Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

3. Infectious and Tropical Diseases Research Center, Health Research Institute Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

4. Student Research Committee Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

5. Department of Nursing, School of Nursing and Midwifery Ilam University of Medical Sciences Ilam Iran

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7375

Reference37 articles.

1. Food Science & Nutrition 9

2. Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome

3. Curcumin (a constituent of turmeric): New treatment option against COVID‐19

4. Cytokine storm in COVID ‐19 and parthenolide: Preclinical evidence

5. Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19;Future Foods;2024-06

2. Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19;Biomedicine & Pharmacotherapy;2024-02

3. Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment;Experimental Biology and Medicine;2023-12-06

4. Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis;Heliyon;2023-11

5. COVID-19 and Nutrition: Focus on Chronic Kidney Disease;Journal of Renal Nutrition;2023-11